These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 13491015)
1. What hospitals should know about investigational drugs; guiding principles in medical research involving humans. SESSOMS SM Hospitals; 1958 Jan; 32(1):44 passim. PubMed ID: 13491015 [No Abstract] [Full Text] [Related]
2. What hospitals should know about investigational drugs; responsibilities of the hospital staff. KERLIKOWSKE AC; FRANCKE DE Hospitals; 1958 Jan; 32(1):45-7. PubMed ID: 13491016 [No Abstract] [Full Text] [Related]
5. Investigational drugs. I. By number. Latiolais CJ; Miller W Am J Hosp Pharm; 1967 Sep; 24(9):526-31. PubMed ID: 6049814 [No Abstract] [Full Text] [Related]
6. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. Finucane TE; Boult CE Am J Med; 2004 Dec; 117(11):842-5. PubMed ID: 15589488 [TBL] [Abstract][Full Text] [Related]
7. The use of investigational drugs in hospitals; a survey. I. TEPLITSKY B Hosp Prog; 1956 Aug; 37(8):76-82. PubMed ID: 13345319 [No Abstract] [Full Text] [Related]
8. The use of investigational drugs in hospitals; a survey. II. TEPLITSKY B Hosp Prog; 1956 Sep; 37(9):106; passim. PubMed ID: 13357155 [No Abstract] [Full Text] [Related]
9. Public-private partnerships: new ways to discover, develop and deliver drugs for tropical diseases. Hentschel CC Southeast Asian J Trop Med Public Health; 2004; 35 Suppl 2():1-4. PubMed ID: 15906625 [No Abstract] [Full Text] [Related]
11. Recent disclosures of clinical drug candidates. Armer R; Warne P; Witherington J Drug News Perspect; 2006; 19(1):65-72. PubMed ID: 16550257 [TBL] [Abstract][Full Text] [Related]
12. Sociology of pharmaceuticals development and regulation: a realist empirical research programme. Abraham J Sociol Health Illn; 2008 Sep; 30(6):869-85. PubMed ID: 18761508 [TBL] [Abstract][Full Text] [Related]
13. [Relatively good safety in Swedish phase I trials. A survey of studies reported to the Medical Products Agency during 3 years]. Glazer A; Hedenmalm K Lakartidningen; 2008 Sep 10-16; 105(37):2482-4. PubMed ID: 19006863 [No Abstract] [Full Text] [Related]
14. Occurrence of pharmaceuticals in Taiwan's surface waters: impact of waste streams from hospitals and pharmaceutical production facilities. Lin AY; Tsai YT Sci Total Environ; 2009 Jun; 407(12):3793-802. PubMed ID: 19345984 [TBL] [Abstract][Full Text] [Related]
15. Problems relating to investigational drugs. KELSEY FO Am J Pharm Sci Support Public Health; 1963 Mar; 135():93-7. PubMed ID: 14031845 [No Abstract] [Full Text] [Related]
16. PMA report on investigational new drugs. J Fla Med Assoc; 1966 Jun; 53(6):519-22. PubMed ID: 5933305 [No Abstract] [Full Text] [Related]
18. Guiding Principles for Pharmaceutical Physicians from the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK. Bickerstaffe R; Brock P; Husson JM; Rubin I; Bragman K; Paterson K; Sommerville A Int J Clin Pract; 2006 Feb; 60(2):238-41. PubMed ID: 16451301 [TBL] [Abstract][Full Text] [Related]
19. Impact of decentralization on health services in Uganda: a look at facility utilization, prescribing and availability of essential drugs. Anokbonggo WW; Ogwal-Okeng JW; Obua C; Aupont O; Ross-Degnan D East Afr Med J; 2004 Feb; Suppl():S2-7. PubMed ID: 15125109 [TBL] [Abstract][Full Text] [Related]